Worldwide Webinar Series:

Impact of Modeling & Simulation in Drug Development

Rosa’s Worldwide Webinar Series fosters the adoption of modeling and simulation by informing a broad audience about the strategic impact it can have on all aspects of research and development.

Since its inception in 2011, this complimentary monthly series has featured select speakers from academia, industry, Rosa client companies, and Rosa itself. The series has drawn many thousands of attendees worldwide from all drug development disciplines.

PLEASE NOTE - ***ALL WEBINARS PRIOR to 2017*** are available by contacting us CLICK HERE 

Sign up to receive Webinar and QSP News Alerts

Subscribe
Date Presenter / Topic Register

Jeff Kearns, Director, Translational Modeling & Simulation, Novartis Biomedical, Cambridge, MA
Jeff Kearns, of Novartis Biomedical, co-leads the translational modeling & simulation group there. In the past, he has held positions in small pharma at Forma Therapeutics and Merrimack Pharmaceuticals. At Novartis, his portfolio spans cardiovascular/metabolic, neuroscience, and renal disease areas and both traditional and novel modalities. In recent years, Jeff has had specific interest in RNAi and has held several modeling and company leadership roles to expand the development of the Novartis RNAi platform.

Mind the PK/PD disconnect: QSP modeling approaches for long-acting RNAi therapeutics
More Info

Haojie Zhu, Professor at the Department of Clinical Pharmacy, University of Michigan College of Pharmacy

August Rosa World-Wide Webinar
More Info